Expression of receptor activator of NF-kB ligand (RANKL) on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma.

被引：0
|
作者：
Heider, U
Jakob, C
Zavrski, I
Langelotz, C
Fleissner, C
Schulz, CO
Eucker, J
Possinger, K
Hofbauer, LC
Sezer, O
机构：
[1] Universitatsklinikum Charite, Dept Hematol & Oncol, Berlin, Germany
[2] Univ Marburg, Dept Gastroenterol Endocrinol & Metab, D-35032 Marburg, Germany
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3190
引用
收藏
页码：808A / 808A
页数：1
相关论文
共 50 条
  • [1] Expression of receptor activator of nuclear factor κB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma
    Heider, U
    Langelotz, C
    Jakob, C
    Zavrski, I
    Fleissner, C
    Eucker, J
    Possinger, K
    Hofbauer, LC
    Sezer, O
    CLINICAL CANCER RESEARCH, 2003, 9 (04) : 1436 - 1440
  • [2] RANK (receptor activator of NF-KB) and RANK ligand expression in multiple myeloma.
    Roux, S
    Meignin, V
    Quillard, J
    Guiochon-Mantel, A
    Milgrom, E
    Mariette, X
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S224 - S224
  • [3] Expression of RANKL in myeloma cell lines and bone marrow plasma cells in patients with multiple myeloma.
    Sezer, O
    Heider, U
    Jakob, C
    Eucker, J
    Niemöller, K
    Zavrski, I
    Possinger, K
    BLOOD, 2001, 98 (11) : 304B - 304B
  • [4] Clinical and biological correlates of CD45 expression on bone marrow plasma cells from patients with multiple myeloma.
    Kumar, S
    Rajkumar, SV
    Kimlinger, T
    Greipp, PR
    Witzig, TE
    BLOOD, 2004, 104 (11) : 918A - 918A
  • [5] THE BISPHOSPHONATE IBANDRONAT REDUCES EXPRESSION OF RECEPTOR ACTIVATOR OF NUCLEAR-KB LIGAND IN BONE MARROW STROMAL CELLS DERIVED FROM MULTIPLE MYELOMA PATIENTS
    Fernandez, M.
    Figueroa, P.
    Rodriguez, J. P.
    Alarcon, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 611 - 611
  • [6] The Increased Expression of Receptor Activator of Nuclear-κB Ligand (RANKL) of Multiple Myeloma Bone Marrow Stromal Cells Is Inhibited by the Bisphosphonate Ibandronate
    Fernandez, Mireya
    Pino, Ana M.
    Figueroa, Paula
    Rodriguez, Juan P.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2010, 111 (01) : 130 - 137
  • [7] Expression of receptor activator of NF-κB ligand (RANKL) mRNA in human multiple myeloma cells
    Heider, U
    Zavrski, I
    Jakob, C
    Bängeroth, K
    Fleissner, C
    Langelotz, C
    Possinger, K
    Hofbauer, LC
    Viereck, V
    Sezer, O
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (08) : 469 - 474
  • [8] Expression of receptor activator of NF-κB ligand (RANKL) mRNA in human multiple myeloma cells
    Ulrike Heider
    Ivana Zavrski
    Christian Jakob
    Katharina Bängeroth
    Claudia Fleissner
    Corinna Langelotz
    Kurt Possinger
    Lorenz C. Hofbauer
    Volker Viereck
    Orhan Sezer
    Journal of Cancer Research and Clinical Oncology, 2004, 130 : 469 - 474
  • [9] Management of Metastatic Bone Disease in the Elderly with Bisphosphonates and Receptor Activator of NF-kB Ligand Inhibitors: Effectiveness and Safety
    Vassiliou, Vassilios
    CLINICAL ONCOLOGY, 2013, 25 (05) : 290 - 297
  • [10] RECEPTOR ACTIVATOR OF NF-KB (RANK) EXPRESSION ASSOCIATES WITH BONE METASTASIS IN BREAST CARCINOMAS
    Santini, D.
    Vincenzi, B.
    Russo, A.
    Ortega, C.
    Porta, C.
    Galluzzo, S.
    La Verde, N.
    Caroti, C.
    Addeo, R.
    Tonini, G.
    ANNALS OF ONCOLOGY, 2010, 21 : 50 - 50
12345